MANILA (UPDATE) - The Regulatory Enforcement Unit of the Food and Drug Administration (FDA) has recommended the revocation of the license to operate of Belo Medical Group's pharmacy in Alabang, Muntinlupa City.
The FDA said the Belo Medical Group allegedly violated certain provisions in the FDA Law and "in view of its gross defiance to obey the legal orders issued by the FDA particularly in refusing to allow FDA personnel to inspect its pharmacy last February 8."
According to FDA, they served the summons with preventive measure order they issued for the inventory and seizure of several health products of the BMG clinic pharmacy in Alabang.
However, the clinic refused to let the FDA and police team from conducting seizure and inspection of the in-house pharmacy.
This prompted the FDA to issue another summons with preventive measure order for the pharmacy to cease and desist from operation last February 19. The FDA said the order will remain until the BMG has complied with all the requirements.
In its recommendation, the FDA alleged that the pharmacy was "operating without the direct supervision of a registered pharmacist."
According to FDA, "the inspectors noticed that the PRC License and Board Certificate of the pharmacist are not displayed in a conspicuous place as required by law."
In a statement, the Belo Medical Group said it has yet to receive the report.
"We cannot comment on the matter as we have yet to receive this report. Once we do, we will verify and respond through the proper venue," said John Eric Ho, Belo's Corporate Communications head.
The Belo Medical Group earlier denied its pharmacy was shut down.
The company also said the FDA found none of the questionable products in their pharmacy upon inspection.